HDAC9 and Parkinson disease: In contrast, treatment with HDAC inhibitors, sodium butyrate and vorinostat, in SH-SY5Y cells or transgenic flies, rescued α-syn-induced toxicity and decreased neuronal cell death, suggesting that HDAC inhibitors may represent a promising therapeutic strategy to mitigate the progressive neurodegeneration linked to PD [36].